Neutralization of SARS-CoV-2 variants by mRNA and adenoviral vector vaccine-elicited antibodies

T Tada, H Zhou, MI Samanovic, BM Dcosta… - Frontiers in …, 2022 - frontiersin.org
The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine effectiveness. Here, neutralizing antibody titers elicited by mRNA …

Comparison of neutralizing antibody titers elicited by mRNA and adenoviral vector vaccine against SARS-CoV-2 variants

T Tada, H Zhou, MI Samanovic, BM Dcosta… - BioRxiv, 2021 - biorxiv.org
The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine efficacy. Here, neutralizing antibody titers elicited by mRNA-based and …

Vaccine-induced antibody responses against SARS-CoV-2 variants-Of-Concern six months after the BNT162b2 COVID-19 mRNA vaccination

P Jalkanen, P Kolehmainen, A Haveri… - Microbiology …, 2022 - Am Soc Microbiol
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
has raised concern about increased transmissibility, infectivity, and immune evasion from a …

A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants

AJ Schmitz, JS Turner, Z Liu, JQ Zhou, ID Aziati… - Immunity, 2021 - cell.com
The emergence of SARS-CoV-2 antigenic variants with increased transmissibility is a public
health threat. Some variants show substantial resistance to neutralization by SARS-CoV-2 …

Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

L Wang, MH Kainulainen, N Jiang, H Di… - Nature …, 2022 - nature.com
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in the emergence of new variant lineages that have exacerbated the COVID-19 …

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

JP Evans, C Zeng, C Carlin, G Lozanski… - Science Translational …, 2022 - science.org
The waning efficacy of SARS-CoV-2 vaccines, combined with the continued emergence of
variants resistant to vaccine-induced immunity, has reignited debate over the need for …

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B. 1.617. 2, B. 1.351, B. 1.1. 7+ E484K and a sub-variant of C. 37

JM Carreño, H Alshammary, G Singh, A Raskin… - medRxiv, 2021 - medrxiv.org
Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) have been developed. However, the emergence of viral variants that are more …

Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: A systematic review and individual data meta-analysis

X Chen, Z Chen, AS Azman, R Sun, W Lu, N Zheng… - 2021 - papers.ssrn.com
Background: Recently emerged SARS-CoV-2 variants may pose a threat to immunity
derived from prototypical SARS-CoV-2 infection or vaccination. A systematic summary of the …

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum

TA Bates, HC Leier, ZL Lyski, SK McBride… - Nature …, 2021 - nature.com
SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the
rollout of effective vaccines. Therefore, it is essential to understand the levels of protection …

Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1

L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin… - MedRxiv, 2021 - medrxiv.org
The emergence of SARS-CoV-2 variants raises concerns about their resistance to
neutralizing antibodies elicited from previous infection, or from vaccination. Here we …